๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of severe postvagotomy/postgastrectomy symptoms with the somatostatin analogue octreotide

โœ Scribed by Mr C. R. Mackie; S. A. Jenkins; M. N. Hartley

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
621 KB
Volume
78
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase III evaluation of a somatostatin
A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma
โœ David L. Morris ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 71 KB ๐Ÿ‘ 3 views

I of a Somatostatin Analogue (Octreotide) in the Treatment of Patients with Asymptomatic Advanced Colon Cancer."' The disappointing results of this study contrast with recently reported cellular kinetic data for rectal cancer treatment with somatostatin. It should be noted that the dosage used in o

Treatment of pancreatic fistula with the
Treatment of pancreatic fistula with the somatostatin analogue SMS 201-995
โœ Dr. B. Ahrรฉn; K.-G. Tranberg; S. Bengmark ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 160 KB ๐Ÿ‘ 1 views

Somatostatin inhibits exocrine pancreatic and has been used for treatment of pancreatic f i ~t u l a ~-~. The short ti, < 3 m i n in man6, and the risk of a rebound effect when treatment is interrupted7, require the peptide to be continuously infused intravenously. This may be circumvented by using